Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko B Lens

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|December 4, 2003
The role of biological response modifiers in malignant melanomaMarko B Lens
International Journal of Pediatric Otorhinolaryngology|February 29, 2008
Contact-diode laser repair of bony choanal atresia: a preliminary reportRiccardo D'Eredità, Marko B Lens
The Lancet. Oncology|June 6, 2003
Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trialsMarko B Lens, Martin Dawes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trialsMarko B Lens, Martin Dawes
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 26, 2009
Anterior tab flap versus standard underlay myringoplasty in childrenRiccardo D'Eredità, Marko B Lens
Expert Opinion on Pharmacotherapy|August 21, 2002
Economic evaluation in evidence-based practiceMarko B Lens, Martin Dawes
Expert Opinion on Pharmacotherapy|December 4, 2003
Systemic chemotherapy in the treatment of malignant melanomaMarko B Lens, Tim G Eisen
Archives of Surgery (Chicago, Ill. : 1960)|September 19, 2007
Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trialsMarko B Lens, Paul Nathan, Veronique Bataille
Cancer|September 26, 2003
Use of tamoxifen in the treatment of malignant melanomaMarko B Lens, Tony Reiman, Amna F Husain
Cancer|January 13, 2004
Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick)Marko B Lens, Julia A Newton-Bishop, Martin Dawes
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|December 4, 2003
The role of biological response modifiers in malignant melanomaMarko B Lens
International Journal of Pediatric Otorhinolaryngology|February 29, 2008
Contact-diode laser repair of bony choanal atresia: a preliminary reportRiccardo D'Eredità, Marko B Lens
The Lancet. Oncology|June 6, 2003
Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trialsMarko B Lens, Martin Dawes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trialsMarko B Lens, Martin Dawes
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 26, 2009
Anterior tab flap versus standard underlay myringoplasty in childrenRiccardo D'Eredità, Marko B Lens
Expert Opinion on Pharmacotherapy|August 21, 2002
Economic evaluation in evidence-based practiceMarko B Lens, Martin Dawes
Expert Opinion on Pharmacotherapy|December 4, 2003
Systemic chemotherapy in the treatment of malignant melanomaMarko B Lens, Tim G Eisen
Archives of Surgery (Chicago, Ill. : 1960)|September 19, 2007
Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trialsMarko B Lens, Paul Nathan, Veronique Bataille
Cancer|September 26, 2003
Use of tamoxifen in the treatment of malignant melanomaMarko B Lens, Tony Reiman, Amna F Husain
Cancer|January 13, 2004
Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick)Marko B Lens, Julia A Newton-Bishop, Martin Dawes
Pageof 2